Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report
Main Authors: | Pasquet, Florian, Combarnous, François, MacGregor, Brigitte, Coppere, Brigitte, Mausservey, Christelle, Ninet, Jacques, Hot, Arnaud |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292813/ |
Similar Items
-
Leukocytoclastic Vasculitis in a Patient with Type 1 Cryoglobulinemia
by: Liu, Paul Y., et al.
Published: (2011) -
The Spectrum of Type I Cryoglobulinemia Vasculitis: New Insights Based on 64 Cases
by: Terrier, Benjamin, et al.
Published: (2013) -
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
by: Stasi, Cristina, et al.
Published: (2014) -
Cutaneous lesions and finger clubbing uncovering hypocomplementemic
urticarial vasculitis and hepatitis C with mixed cryoglobulinemia*
by: Pinto-Almeida, Teresa, et al.
Published: (2013) -
Hepatitis-B Associated Cryoglobulinemia Presenting as Pseudoleucocytosis
by: Yadav, Yogesh Kr., et al.
Published: (2011)